We were born in 2020 with years of history
We are an Istanbul based pharma solutions company functioning predominantly in Turkey and the Middle East. Trispera’s name derives from Latin words “tri” (three) and “spera” (trust), denoting the presence of the initial trio during the foundation of the company. Founded in March of 2020, we are a young and dynamic team bringing about years of practice and know-how in the interdisciplinary backgrounds of pharma industry, healthcare, marketing and digital design and development.
Trispera finds its roots in Dr. Kivanc Oztuzun's extensive experience in some of the prestigious global pharmaceutical companies such as AstraZeneca, Sanofi Genzyme and Rhythm Pharmaceuticals in different medical positions after working as a physician under the provision of the Turkish Ministry of Health.
Our core interest is rare diseases. A rare disease could be roughly defined as any disease that affects a very small percentage of the population.There are approximately 7000 different rare diseases identified to this day. While diseases may be rare when they are singled out, the total accumulation of the rare disorders combined currently affects 3.5% - 6% of the worldwide population, an estimated 5 million people in Turkey, 30 million in Europe and 300 million worldwide. Our mission is to be one of the foremost names in the rare disease solutions in our region, and we imagine a world where no one with a rare disease is left without treatment.
Kivanc Oztuzun, MD, MBA
Founder and Managing Director
